UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: B | C | D | E | F | G | H | J | K | L | M | P | R | T | U | W
Number of items: 40.

B

Bangham, M; Goldstein, R; Walton, H; Ledermann, JA; (2016) Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease. Gynecologic Oncology Reports , 18 pp. 22-24. 10.1016/j.gore.2016.10.004. Green open access
file

Beeken, RJ; Croker, H; Heinrich, M; Smith, L; Williams, K; Hackshaw, A; Hines, J; ... Fisher, A; + view all (2016) Study protocol for a randomised controlled trial of brief, habit-based, lifestyle advice for cancer survivors: exploring behavioural outcomes for the Advancing Survivorship Cancer Outcomes Trial (ASCOT). BMJ Open , 6 (11) , Article e011646. 10.1136/bmjopen-2016-011646. Green open access
file

Bridgewater, J; Lopes, A; Beare, S; Duggan, M; Lee, D; Ricamara, M; McEntee, D; ... Valle, JW; + view all (2016) A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study. BMC Cancer , 16 (1) p. 153. 10.1186/s12885-016-2174-8. Green open access
file

Brown, N; McBain, C; Nash, S; Hopkins, K; Sanghera, P; Saran, F; Phillips, M; ... Mulholland, P; + view all (2016) Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma. PLoS ONE , 11 (5) 10.1371/journal.pone.0156369. Green open access
file

C

Childs, A; Kirkwood, A; Edeline, J; Tu, VL; Watkins, J; Lamarca, A; Alrifai, D; ... Meyer, T; + view all (2016) Ki-67 index and response to chemotherapy in patients with neuroendocrine tumours. Endocrine-Related Cancer , 23 (7) pp. 563-570. 10.1530/ERC-16-0099. Green open access
file

D

De Ruysscher, D; Lueza, B; Le Péchoux, C; Johnson, DH; O'Brien, M; Murray, N; Spiro, S; ... RTT-SCLC Collaborative Group, ; + view all (2016) Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis. Annals of Oncology , 27 (10) pp. 1818-1828. 10.1093/annonc/mdw263. Green open access
file

de Boer, SM; Powell, ME; Mileshkin, L; Katsaros, D; Bessette, P; Haie-Meder, C; Ottevanger, PB; ... Creutzberg, CL; + view all (2016) Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial. Lancet Oncology , 17 (8) pp. 1114-1126. 10.1016/S1470-2045(16)30120-6. Green open access
file

E

Eminowicz, GKD; (2016) Standardisation and optimisation of radical radiotherapy for cervical cancer. Doctoral thesis , UCL (University College London). Green open access
file

F

Forster, M; Mendes, R; Harrington, K; Guerrero-Urbano, T; Baines, H; Spanswick, V; Ensell, L; ... Beare, S; + view all (2016) A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC). Presented at: 2016 ASCO Annual Meeting, Chicago, IL, USA. Green open access
file

G

Gleeson, M; Hawkes, EA; Cunningham, D; Chadwick, N; Counsell, N; Lawrie, A; Jack, A; ... Linch, D; + view all (2016) Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial. British Journal of Haematology , 175 (4) pp. 668-672. 10.1111/bjh.14287. Green open access
file

Grunewald, T; Ledermann, JA; (2016) Targeted Therapies for Ovarian Cancer. Best Practice & Research Clinical Obstetrics & Gynaecology 10.1016/j.bpobgyn.2016.12.001. (In press). Green open access
file

H

Heinrich, M; Fisher, A; Paton, B; McCourt, O; Beeken, RJ; Hackshaw, A; Wardle, J; (2016) Lifestyle in Multiple Myeloma - a longitudinal cohort study protocol. BMC Cancer , 16 , Article 387. 10.1186/s12885-016-2407-x. Green open access
file

Hirst, Y; Kerrison, R; Kobayashi, LC; Counsell, N; Djedovic, N; Ruwende, J; Stewart, M; (2016) Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial. BMC Public Health 10.1186/s12889-016-2733-6. Green open access
file

J

Johnson, P; Federico, M; Kirkwood, A; Fossa, A; Berkahn, L; Carella, A; d'Amore, F; ... Barrington, S; + view all (2016) Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. New England Journal of Medicine , 374 (25) pp. 2419-2429. 10.1056/NEJMoa1510093. Green open access
file

K

Kerrison, R; McGregor, LM; Marshall, S; Isitt, J; Counsell, N; Wardle, J; Von Wagner, C; (2016) Use of a twelve month's self referral reminder to faciliate uptake of bowel scope (flexible sigmoidoscopy screening) in previous non-responders: a London-based feasibility study. British Journal of Cancer , 114 pp. 751-758. 10.1038/bjc.2016.43. Green open access
file

Kerrison, RS; McGregor, LM; Marshall, S; Isitt, J; Counsell, N; Wardle, J; von Wagner, C; (2016) Use of a 12 months' self-referral reminder to facilitate uptake of bowel scope (flexible sigmoidoscopy) screening in previous non-responders: a London-based feasibility study. British Journal of Cancer , 114 (7) pp. 751-758. 10.1038/bjc.2016.43. Green open access
file

Khoja, L; Nolan, K; Mekki, R; Milani, A; Mescallado, N; Ashcroft, L; Hasan, J; ... Jayson, GC; + view all (2016) Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UK. Clinical Oncology , 28 (12) pp. 760-765. 10.1016/j.clon.2016.06.011. Green open access
file

Kularatne, B; Arora, R; Elshstein, G; Guppy, N; Kirkwood, A; Meyer, T; Kristeleit, RS; (2016) Immunohistochemistry (IHC) evaluation of a novel 4-protein prognostic and predictive biomarker panel in endometrial cancer (EC). In: Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmar. Oxford University Press (OUP): Policy A1 Green open access
file

L

Landau, DB; Hughes, L; Baker, A; Bates, AT; Bayne, MC; Counsell, N; Garcia-Alonso, A; ... Fenwick, JD; + view all (2016) IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer. International Journal of Radiation Oncology - Biology - Physics , 95 (5) pp. 1367-1377. 10.1016/j.ijrobp.2016.03.031. Green open access
file

Ledermann, JA; (2016) PARP inhibitors in ovarian cancer. Annals of Oncology , 27 (Suppl 1) i40-i44. 10.1093/annonc/mdw094. Green open access
file

Ledermann, JA; Drew, Y; Kristeleit, RS; (2016) Homologous recombination deficiency and ovarian cancer. European Journal of Cancer , 60 pp. 49-58. 10.1016/j.ejca.2016.03.005. Green open access
file

Ledermann, JA; Embleton, AC; Raja, F; Perren, TJ; Jayson, GC; Rustin, GJS; Kaye, SB; ... Collaborators, I; + view all (2016) Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet , 387 (10023) pp. 1066-1074. 10.1016/S0140-6736(15)01167-8. Green open access
filefile

Ledermann, JA; Harter, P; Gourley, C; Friedlander, M; Vergote, I; Rustin, G; Scott, C; ... Matulonis, U; + view all (2016) Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer. British Journal of Cancer , 115 (11) pp. 1313-1320. 10.1038/bjc.2016.348. Green open access
file

Ledermann, JA; Harter, P; Gourley, C; Friedlander, M; Vergote, I; Rustin, G; Scott, C; ... Matulonis, U; + view all (2016) Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial. The Lancet Oncology , 17 (11) pp. 1579-1589. 10.1016/S1470-2045(16)30376-X. Green open access
file

Lee, SM; Falzon, M; Blackhall, F; Spicer, J; Nicolson, M; Chaudhuri, A; Middleton, G; ... Hackshaw, A; + view all (2016) Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET). Journal of Clinical Oncology , 35 (4) pp. 402-411. 10.1200/JCO.2016.68.1841. Green open access
file

Lemech, CR; Ensell, L; Paterson, JC; Eminowicz, G; Lowe, H; Arora, R; Arkenau, H-T; ... Kristeleit, RS; + view all (2016) Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer. Oncology , 91 (1) pp. 48-54. 10.1159/000445999. Green open access
file

M

Mateo, J; Moreno, V; Gupta, A; Kaye, SB; Dean, E; Middleton, MR; Friedlander, M; ... Molife, LR; + view all (2016) An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib. Targeted Oncology , 11 (3) pp. 401-415. 10.1007/s11523-016-0435-8. Green open access
filefilefile

McGregor, L; Von Wagner, C; Atkin, W; Kralj-Hans, I; Halloran, S; Handley, G; Logan, R; ... Wardle, J; + view all (2016) Reducing the social gradient in uptake of the NHS Colorectal Cancer Screening Programme using a narrative-based information leaflet: a cluster-randomised trial. Gastroenterology Research and Practice , 2016 , Article 3670150. 10.1155/2016/3670150. Green open access
file

Miller, RE; Ledermann, JA; (2016) The status of poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors in ovarian cancer, part 1: olaparib. Clinical Advances in Hematology & Oncology , 14 (8) pp. 619-627. Green open access
file

Miller, RE; Ledermann, JA; (2016) The status of poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors in ovarian cancer, part 2: extending the scope beyond olaparib and BRCA1/2 mutations. Clinical Advances in Hematology & Oncology , 14 (9) pp. 704-711. Green open access
file

Mirza, MR; Monk, BJ; Herrstedt, J; Oza, AM; Mahner, S; Redondo, A; Fabbro, M; ... ENGOT-OV16/NOVA Investigators, ; + view all (2016) Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. The New England Journal of Medicine , 375 (22) pp. 2154-2164. 10.1056/NEJMoa1611310. Green open access
file

P

Patel, B; Kirkwood, AA; Dey, A; Marks, DI; McMillan, AK; Menne, TF; Micklewright, L; ... Fielding, AK; + view all (2016) Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial. Leukemia 10.1038/leu.2016.219. Green open access
file

Perna, C; Eminowicz, G; Asghar, U; Imseeh, G; Kirkwood, A; Mitra, A; Arora, R; ... McCormack, M; + view all (2016) Uterine carcinosarcoma: a retrospective clinical cohort analysis. Presented at: ESMO 2016: 41st ESMO Congress, Copenhagen, Denmark. Green open access
file

R

Raine, R; Duffy, SW; Wardle, J; Solmi, F; Morris, S; Howe, R; Kralj-Hans, I; ... Atkin, W; + view all (2016) Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening. British Journal of Cancer , 114 pp. 321-326. 10.1038/bjc.2015.413. Green open access
file

Raine, R; Moss, SM; von Wagner, C; Atkin, W; Hans, IK; Howe, R; Solmi, F; ... Duffy, SW; + view all (2016) A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening. British Journal of Cancer , 115 (12) pp. 1479-1486. 10.1038/bjc.2016.365. Green open access
file

T

Townsend, W; Johnson, RJ; Pottinger, BT; Counsell, N; Smith, P; Chadwick, H; Evans, K; ... Rudin, CE; + view all (2016) A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320. Leukemia & Lymphoma , 57 (9) pp. 2232-2234. 10.3109/10428194.2015.1133814. Green open access
file

U

UK CLL Forum, ; (2016) Ibrutinib for relapsed/refractory chronic lymphocytic leukemia: a UK and Ireland analysis of outcomes in 315 patients. Haematologica , 101 (12) pp. 1563-1572. 10.3324/haematol.2016.147900. Green open access
file

W

Wardle, J; von Wagner, C; Kralj-Hans, I; Halloran, SP; Smith, SG; McGregor, LM; Vart, G; ... Raine, R; + view all (2016) Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials. The Lancet , 387 (10020) pp. 751-759. 10.1016/S0140-6736(15)01154-X. Green open access
file

Wheeler, GM; (2016) Incoherent dose-escalation in phase I trials using the escalation with overdose control approach. Statistical Papers pp. 1-11. 10.1007/s00362-016-0790-7. Green open access
file

Wheeler, GM; Sweeting, MJ; Mander, AP; (2016) AplusB: A Web Application for Investigating A plus B Designs for Phase I Cancer Clinical Trials. PLOS ONE , 11 (7) , Article e0159026. 10.1371/journal.pone.0159026. Green open access
file

This list was generated on Thu Apr 22 12:54:47 2021 BST.